Cancer in Pacific people in New Zealand

Cancer Causes and Control

Volumn 23, Issue 7, 2012, Pages 1173-1184

  Meredith, Ineke ^a   Sarfati, Diana ^a   Ikeda, Takayoshi ^a   Blakely, Tony ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cancer incidence; Ethnicity; New Zealand; Pacific

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; EUROPE; FEMALE; GALLBLADDER CANCER; HEPATITIS B; HUMAN; IMMOBILIZATION; LIP CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; NEOPLASM; NEW ZEALAND; OBESITY; OVARY CANCER; PANCREAS CANCER; PAPILLOMAVIRUS INFECTION; PHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COMMUNICABLE DISEASES; EUROPE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; NEW ZEALAND; OBESITY; PACIFIC ISLANDS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 84862492450     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9986-x     Document Type: Article

References (86)

1. Medical Council of New Zealand (2010) Best outcomes for Pacific peoples: practice implications. Wellington, New Zealand
2. Foliaki S, Pearce N (2003) Prevention and control of diabetes in Pacific people. BMJ 327(7412):437-439 (Pubitemid 37046791)
3. Tukuitonga C (2011) Pacific peoples in New Zealand. In: St George I (ed) Cole's Medical Practice in New Zealand, 10th edn. Medical Council of New Zealand, Wellington, pp 61-67
4. Tobias M, Yeh L (2009) How much does health care contribute to health gain and to health inequality? Trends in amenable mortality in New Zealand 1981-2004. Aust N Z J Public Health 33:70-78
5. Blakely T, Tobias M, Atkinson J, Yeh L-C, Huang K (2007) Tracking disparity: trends in ethnic and socioeconomic inequalities in mortality, 1981-2004. Ministry of Health, Wellington
6. Shaw C, Atkinson J, Blakely T (2009) (Mis)classification of ethnicity on the New Zealand Cancer Registry: 1981-2004. N Z Med J 122(1294):10-22
7. Kost ER, Hall KL, Hines JF, Farley JH, Nycum LR, Rose GS, Carlson JW, Fischer JR, Kendall BS (2003) Asian-Pacific Islander race independently predicts poor outcome in patients with endometrial cancer. Gynecol Oncol 89:218-226 (Pubitemid 36457868)
8. Miller BA, Chu KC, Hankey BF, Ries LAG (2008) Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the US. Cancer Causes Control 19:227-256
9. Dachs GU, Currie MJ, McKenzie F, Jeffreys M, Cox B, Foliaki S, Le Marchand L, Robinson BA (2008) Cancer disparities in indigenous Polynesian populations: Maori, Native Hawaiians, and Pacific people. Lancet Oncol 9:473-484 (Pubitemid 351618082)
10. Blakely T, Shaw C, Atkinson J, Cunningham R, Sarfati D (2011) Social inequalities or inequities in cancer incidence? Repeated census-cancer cohort studies, New Zealand 1981-1986 to 2001-2004. Cancer Causes Control 22:1307-1318
11. Atkinson J, Shaw C, Blakely T, Stanley J, SloaneK(2010) Linkage of census and cancer registrations, 1981-2004. CancerTrends Technical Report 1. University of Otago, Wellingtonhttp://www.otago.ac.nz/wellington/research/hirp/ projects/otago020023.html
12. Blakely T, Shaw C, Atkinson J, Tobias M, Bastiampillai N, Sloane K, Sarfati D, Cunningham R (2010) CancerTrends: trends in cancer incidence by ethnic and socioeconomic group, New Zealand 1981-2004. University of Otago, and Ministry of Health, Wellington. http://www.otago.ac.nz/wellington/research/hirp/ projects/otago020023.html
13. R Development Core Team (2011) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
14. International Agency for Research on Cancer (2004) Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 83:1-1438
15. Sherman ME, Devesa SS (2003) Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer 98:176-186 (Pubitemid 36741140)
16. Wright JD, Fiorelli J, Schiff PB, Burke WM, Kansler AL, Cohen CJ, Herzog TJ (2009) Racial disparities for uterine corpus tumors. Changes in clinical characteristics and treatment over time. Cancer 115:1276-1285
17. Setiawan VW, Pike MC, Kolonel LN, Nomura AM, Goodman MT, Henderson BE (2007) Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study. Am J Epidemiol 165:262-270 (Pubitemid 46178272)
18. Voskuil DW, Monninkhof EM, Elias SG, Vlems FA, van Leeuwen FE, Task Force Physical Activity and Cancer (2007) Physical Activity and Endometrial Cancer Risk, a Systematic Review of Current Evidence. Cancer Epidemiol Biomarkers Prev 16(4): 639-648 (Pubitemid 46650563)
19. Terry P, Baron JA, Weiderpass E, Yuen J, Lichtenstein P, Nyren O (1999) Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer 82:38-42 (Pubitemid 29266104)
20. Ministry of Health (2008) A portrait of health: key results of the 2006/07 New Zealand health survey. Ministry of Health, Wellington
21. Vainio H, Bianchini F (eds) (2002) Weight control and physical activity: IARC handbooks of cancer prevention. IARC press, Lyon
22. Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, Webb PM (2007) Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 43:690-709 (Pubitemid 46502901)
23. Weiderpass E, Ye W, Vainio H, Kaaks R, Adam H (2002) Diabetes mellitus and ovarian cancer (Sweden). Cancer Causes Control 13:759-764 (Pubitemid 35204052)
24. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70:950-953 (Pubitemid 24331093)
25. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, Persson I (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2:307-314
26. O'Mara BM, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 38:435-441 (Pubitemid 15025864)
27. Olsen CM, Bain CJ, Jordan SJ, Nagle CM, Green AC, Whiteman DC, Webb PM and Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group (2007) Recreational physical activity and epithelial ovarian cancer: a case-control study, systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 16(11):2321-2330
28. Whittemore AS, Harris R, Itnyre J, and the Collaborative Ovarian Cancer Group (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 136(10):1184-1203 (Pubitemid 23026890)
29. Riman T, Nilsson S, Persson IR (2004) Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 83(9):783-795 (Pubitemid 39179432)
30. Chionh F, Baglietto L, Krishnan K, English DR, MacInnis RJ, Gertig DM, Hopper JL, Giles GG (2010) Physical activity, body size and composition, and risk of ovarian cancer. Cancer Causes Control 21:2183-2194
31. Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90:1774-1786
32. Fathalla MF (1971) Incessant ovulation-a factor in ovarian neoplasia? Lancet 2:163
33. Ministry of Social Development (2011) The social report 2010. http://socialreport.msd.govt.nz/people/fertility.html. Accessed Sept 2011
34. Dharmalingam A, Pool I, Dickson J (2000) Biosocial determinants of hysterectomy in New Zealand. Am J Public Health 90:1455-1458
35. Ministry of Health (2011) Report of the parliamentary review committee regarding the New Zealand Cervical Screening Programme, 22 June 2011. Ministry of Health, Wellington
36. National Screening Unit (December, 2010) National Cervical Screening Programme. Monitoring Report Number 32, 1 July-31 Dec 2009. NSU
37. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
38. Shaw C, Blakely T, Sarfati D, Fawcett J, Hill S (2005) Varying evolution of the New Zealand lung cancer epidemic by ethnicity and socioeconomic position (1981-1999). N Z Med J 118(U1213): U1411 [see comment]
39. Lopez AD, Collishaw NE, Piha T (1994) A descriptive model of the cigarette epidemic in developed countries. Tob Control 3(3): 242-247
40. New Zealand Parliament (2011) Government response to the report of the Maori Affairs Committee on its inquiry into the tobacco industry in Aotearoa and the consequences of tobacco use for Maori (Final Response). New Zealand Parliament, Wellinton
41. Office of the Surgeon General (2004) The health consequences of smoking: a report of the Surgeon General. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Washington, DC
42. Stadtländer CTK-H, Waterbor JW (1999) Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 20(12):2195-2207 (Pubitemid 30015889)
43. WHO (2011) Cancer. Fact sheet no. 297. February 2011. www.who.int/mediacentre/factsheets/fs297/en/. Accessed Aug 2011
44. O'Connor F, Buckley M, O'Morain C (1996) Helicobacter pylori: the cancer link. J R Soc Med 89:674-678 (Pubitemid 27026240)
45. Fraser AG, Ali MR, McCullough S, Haystead A (1996) Diagnostic tests for Helicobacter pylori-can they help select patients for endoscopy? N Z Med J 109:95-98 (Pubitemid 126527753)
46. Fraser AG, Scragg R, Metcalf P, McCullough S, Yeates NJ (1996) Prevalence of Helicobacter pylori infection in different ethnic groups in New Zealand children and adults. Aust N Z J Med 26:646-651 (Pubitemid 26395596)
47. McCallion WA, Murray LJ, Bailie AG, Dalzell AM, O'Reilly DP, Bamford KB (1996) Helicobacter pylori infection in children: relation with current household living conditions. Gut 39:18-21 (Pubitemid 26239097)
48. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, Abnet CC, Albanes D, Virtamo J, Taylor PR (2006) Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 98:1445-1452 (Pubitemid 44605589)
49. Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. J Clin Epi 56:1-9 (Pubitemid 36183309)
50. Yuen MF, Hou JL, Chutaputti A, on behalf of the Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma (2009) Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol 24(3):346-353
51. McGlynn KA, London WT (2011) The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 15: 223-243
52. Yang JD, Roberts LR (2010) Epidemiology and management of hepatocellular carcinoma. Infect Dis Clin North Am 24(4): 899-919
53. Blakely TA, Bates MN, Baker MG, Tobias M (1999) Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand. Int J Epidemiol 28:204-210 (Pubitemid 29176645)
54. Reid S (2006) Evolution of the New Zealand childhood immunisation schedule from 1980: a personal view. N Z Med J 119(1236). http://journal.nzma. org.nz/journal/119-1236/2035/. Accessed Sept 2011
55. Larsson SC, Wolk A (2007) Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 97: 1005-1008 (Pubitemid 47519294)
56. Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen Y, Li G, Wang L (2011) Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer 130(7):1639-1648
57. Hashimoto E, Yatsuji S, Tobari M, Taniai M, Torii N, Shiratori K (2009) Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 44:89-95
58. Kawada N, Imanaka K, Kawaguchi T, Tamai C, Ishihara R, Matsunaga T, Gotoh K, Yamada T, Tomita Y (2009) Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol 44:1190-1194
59. Farrell GC (2003) Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 18:124-138
60. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS (2002) NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36:1349-1354
61. Guzman G, Brunt E, Petrovic L, Chejfec G, Layden TJ, Cotler SJ (2008) Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Arch Pathol Lab Med 132(11):1761-1766
62. Yasui K, Hashimoto E, Komorizono Y, Koike K, Arli S, Imai Y, Shima T, Kanbara Y, Saibara T, Mori T, Kawata S, Uto H et al (2011) Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol 9(5):428-433
63. Arnold LD, Patel AV, Yan Y, Jacobs EJ, Thun MJ, Calle EE, Colditz GA (2009) Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity? Cancer Epidemiol Biomarkers Prev 18(9):2397-2405
64. Paksoy N, Bouchardy C, Parkin DM (1991) Cancer Incidence in Western Samoa. Int J Epidemiol 20(3):634-641
65. Moore MA, Baumann F, Foliaki S, Goodman MT, Haddock R, Maraka R, Koroivueta J, Roder D, Vinit T, Whippy HJ, Sobue T (2010) Cancer epidemiology in the Pacific Islands - past, present and future. Asian Pacific J Cancer Prev 11:99-106
66. Smith AH, Pearce NE, Joseph JG (1985) Major colorectal cancer aetiological hypotheses do not explain mortality trends among Maori and non-Maori New Zealanders. Int J Epidemiol 14(1): 79-85 (Pubitemid 15109497)
67. Blot WJ, Marchand LL, Boice JD, Henderson BE (1997) Thyroid cancer in the Pacific. J Natl Cancer Inst 89(1):90-91
68. Maso LD, Bosetti C, La Vecchia C, Franceschi S (2009) Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20:75-86
69. Brindel P, Doyon F, Rachedi F, Boissin JL, Sebbag J, Shan L, Chungue V, Sun LY, Bost-Bezeaud F, Petitdidier P, Paoaafaite J, Teuri J et al (2008) Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol 167:219-229
70. Brown LM, Gridley G, Pottern LM, Baris D, Swanso CA, Silverman DT, Hayes RB, Greenberg RS, Swanson GM, Schoenberg JB, Schwartz AG, Fraument JF Jr (2001) Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States. Cancer Causes Control 12:117-125 (Pubitemid 32165269)
71. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569-578 (Pubitemid 351232031)
72. Sarfati D, Shaw C, Blakely T, Atkinson J, Stanley J (2011) Ethnic and Socioeconomic trends in testicular cancer incidence in New Zealand. Int J Cancer 128:1683-1691
73. Thomas TL, Waxweiler RJ (1986) Brain tumors and occupational risk factors. Scand J Work Environ Health 12:1-15 (Pubitemid 16133508)
74. Grufferman S, Delzell E (1984) Epidemiology of Hodgkin's disease. Epidemiol Rev 6:76-106 (Pubitemid 14024790)
75. Cunningham R, Shaw C, Blakely T, Atkinson J, Sarfati D (2010) Ethnic and socioeconomic trends in breast cancer incidence in New Zealand. BMC Cancer 10:674
76. Weston MK, Moss DP, Stewart J, Hill AG (2008) Differences in breast cancer biological characteristics between ethnic groups in New Zealand. Breast Cancer Res Treat 111:555-558
77. McKenzie F, Jeffreys M, Mannetje A, Pearce N (2008) Prognostic factors in women with breast cancer: inequalities by ethnicity and socioeconomic position in New Zealand. Cancer Causes Control 19:403-411
78. Choi YH, Ahn JH, Kim SB, Jung KH, Gong GY, Kim MJ, Son BH, Shn SH, Kim WK (2009) Tissue microarray-based study of patients with lymph node-negative breast cancer shows that HER2/neu overexpression is an important predictive marker of poor prognosis. Ann Oncol 20:1337-1343
79. Waitemata DHB Hospital Advisory Committee (2011) Waitemata DHB Breastscreen Waitemata Northland (BSWN) Breastscreen Service. http://www.waitematadhb.govt.nz/LinkClick.aspx?fileticket=4s9RSWmJolg%3D& tabid=312&mid=769. Accessed Sept 2011
80. Franceschi S, Favero A, La Vecchia C, Baron AE, Negri E, Dal Maso L, Giacosa A, Montella M, Conti E, Amadori D (1996) Body size indices and breast cancer risk before and after menopause. Int J Cancer 67:181-186 (Pubitemid 26274146)
81. Tavani A, Gallus S, La Vecchia C, Negri E, Montella M, Dal Maso L, Franceschi S (1999) Risk factors of breast cancer in women under 40 years. Eur J Cancer 35:1361-1367 (Pubitemid 29397437)
82. La Vecchia C, Giordano SH, Hortobagyi GN, Chabner B (2011) Overweight, obesity, diabetes and risk of breast cancer: interlocking pieces of the puzzle. Oncologist 16:726-729
83. Sneyd MJ, Cox B, Paul C, Skegg D (2003) PSA testing and digital rectal examination in New Zealand. Aust N Z J Public Health 27:502-506 (Pubitemid 37287679)
84. Pokorny MR, Scott DJ (2011) Do Maori and Pacific Islander men present with more advanced prostate cancer than European New Zealand men? An analysis of 486 men undergoing biopsy in Auckland. BJU Int 107(s3):27-32
85. Nacey JN, Morum P, Delahunt B (1995) Analysis of the prevalence of voiding symptoms in Maori, Pacific Island and Caucasian New Zealand men. Urology 46:506-511 (Pubitemid 26100433)
86. Krieger N (2005) Defining and investigating social disparities in cancer: critical issues. Cancer Causes Control 16:5-14